Virani Shafique

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$5.3M

Insider Activity of Virani Shafique

According to the SEC Form 4 filings, Virani Shafique, being in a position of

  1. Chief Business Officer at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 72000 shares for $600,120,
    over all time since 2022-08-15, has bought 0 shares, and sold 500119 shares for $5.3M.

The largest sale of all time was on 2023-07-18 and amounted to 30000 shares of Recursion Pharmaceuticals, Inc. for $412,200.

Biography of Virani Shafique

No biography is available at this moment.

2024-01-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0085%
$10.93$196,740-17.6%
2023-12-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0083%
$9.60$172,800-5.71%
2023-11-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0076%
$6.51$117,180+22.1%
2023-10-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0082%
$6.30$113,400+31.45%
2023-09-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0086%
$8.66$155,880+0.23%
2023-08-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
18,000
0.0094%
$9.25$166,500-5.33%
2023-07-26SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
20,000
0.011%
$14.41$288,200-34.76%
2023-07-25SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
20,000
0.0102%
$14.30$286,000-39.5%
2023-07-18SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
30,000
0.0158%
$13.74$412,200-34.41%
2023-07-17SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
30,000
0.0137%
$11.72$351,600-32.94%
2023-06-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
30,000
0.0165%
$9.41$282,300-0.56%
2023-06-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
30,000
0.0163%
$9.67$290,100-4.62%
2023-06-02SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
17,865
0.0101%
$8.93$159,534+8.38%
2023-06-01SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
25,000
0.0128%
$8.58$214,500+1.71%
2023-02-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
1,768
0.001%
$8.42$14,887+1.41%
2023-02-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
7,486
0.0039%
$8.33$62,358-6.58%
2023-01-17SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
10,000
0.0052%
$9.16$91,561-14.11%
2023-01-17SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
20,000
0.0104%
$9.16$183,122-14.11%
2022-12-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
10,000
0.006%
$8.85$88,525-9.68%
2022-12-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Business Officer
20,000
0.0119%
$8.85$177,050-9.68%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.